PBE · Invesco

Invesco Biotechnology & Genome ETF

See how 33 reported holdings combine into this ETF’s P/E and P/S. Market value, signed ordinary earnings and revenue are added before each ratio is calculated.

Holdings dated 30 April 2026Price US$97.59 as of 21 August 2026Coverage limitations apply

Core valuation

Trailing P/E66.78×96.70% coverage
Latest-quarter run-rate P/E-48.35×96.70% coverage
Trailing P/S4.73×96.70% coverage
Latest-quarter run-rate P/S4.57×96.70% coverage

Coverage is the share of positive eligible-equity holding value represented in each metric. The published holdings account for 100.07% of fund weight. The reliability standard requires at least 90.00% disclosed fund weight and metric coverage, with no individual uncovered holding above 1.00%.

Largest reported holdings

HoldingWeightTrailing P/ETrailing P/S
UTHRUnited Therapeutics Corp.6.28%16.92×6.87×
ILMNIllumina, Inc.5.37%40.16×7.37×
BIIBBiogen Inc.5.05%23.33×3.22×
INCYIncyte Corp.4.91%17.83×4.76×
ALNYAlnylam Pharmaceuticals, Inc.4.84%99.85×8.44×
REGNRegeneron Pharmaceuticals, Inc.4.77%20.31×6.02×
AMGNAmgen Inc.4.71%30.40×6.37×
GILDGilead Sciences, Inc.4.62%19.69×6.10×
BCRXBioCryst Pharmaceuticals, Inc.3.42%-5.30×2.74×
CPRXCatalyst Pharmaceuticals, Inc.3.30%UnavailableUnavailable

Top 10 of 33 reported holdings. * A holding uses its latest full-year result only when both trailing and latest-quarter inputs are unavailable; open the stock for the exact year end.

Most similar funds

Ranked by shared weight across matching disclosed company holdings and explicitly reported same-currency cash.

  1. IBBQ · Invesco Nasdaq Biotechnology ETF100.00% holdings overlap · US market
  2. FBT · First Trust NYSE Arca Biotechnology Index Fund44.83% holdings overlap · NYSE Arca
  3. IBB · iShares Biotechnology ETF32.73% holdings overlap · US market
  4. BMED · iShares Health Innovation Active ETF20.85% holdings overlap · NYSE Arca
  5. GNOM · Global X Genomics & Biotechnology ETF20.70% holdings overlap · Nasdaq

Sources and limitations

Holdings are sourced from Invesco and company financial inputs retain primary-source links. Monetary values are normalised to USD. Corporate actions, reporting lags, unmapped securities and cash can create differences from provider figures.

Open official holdings source

Research holdings date: 30 April 2026. Informational research, not investment advice.

Wide tables can scroll horizontally.

ratio/fox calculates each ETF’s real P/E and P/S as if it was one single company.

ETFs

Loading ETF list
Page loading
ETFs with look-through P/E and P/S valuation and source details
ticker ETF P/E · trailing P/E · quarter P/S · trailing P/S · quarter issuer market listed on current price currency price in original currency price date price provider listing type relationship primary benchmark holdings forward P/E fwd P/E min fwd P/E max forward P/S fwd P/S min fwd P/S max earnings yield fwd earnings yield sales yield fwd sales yield trailing P/E value gap fwd P/E value coverage fwd P/E value gap trailing P/S value coverage trailing P/S value gap fwd P/S value coverage fwd P/S value gap coverage notes
Loading ETF list...